Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

QGC-606 prevents LV dysfunction in mice post-MI

Sep. 3, 2021

Loss of fbn2b tied to cardiovascular manifestations overlapping with Marfan syndrome

Sep. 1, 2021

New heart failure animal model also captures arrhythmia susceptibility

Aug. 31, 2021

Increased atrial proarrhythmic activity seen in murine model of OSA

Aug. 31, 2021

Stressed fat cells send mitochondria to teach heart cells self-defense

Aug. 27, 2021

FDA clears IND for phase II study of CardiolRx for acute myocarditis

Aug. 25, 2021

Pirfenidone shows favorable effects in patients with HFpEF

Aug. 18, 2021

Positive phase II data published from GENETIC-AF study of bucindolol in patients with heart failure

Aug. 6, 2021

LSD1 as potential therapeutic target in heart failure

Aug. 4, 2021

Xenon Pharmaceuticals targets Nav1.5 with aryl sulfonamide inhibitors

July 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...